RBPWorld - a comprehensive database of RNA Binding Proteins

Drugs target to TNC

Drug name	Drug type	Disease/phenotype	Mechanism of action(MoA)	Phase	Status	Source
81C6 131I	Antibody	neuroblastoma	Tenascin binding agent	1.0	Completed	ClinicalTrials
TENATUMOMAB	Antibody	upper aerodigestive tract neoplasm	Tenascin other	1.0	Terminated	ClinicalTrials
TENATUMOMAB	Antibody	pancreatic neoplasm	Tenascin other	1.0	Terminated	ClinicalTrials
TENATUMOMAB	Antibody	non-Hodgkins lymphoma	Tenascin other	1.0	Terminated	ClinicalTrials
TENATUMOMAB	Antibody	respiratory system neoplasm	Tenascin other	1.0	Terminated	ClinicalTrials
F16IL2	Antibody	acute myeloid leukemia	Tenascin other	1.0	Active, not recruiting	ClinicalTrials
F16SIP 131I	Antibody	cancer	Tenascin binding agent	1.0	Completed	ClinicalTrials
F16IL2	Antibody	breast cancer	Tenascin other	1.0	Terminated	ClinicalTrials
81C6 131I	Antibody	Central Nervous System Neoplasm	Tenascin binding agent	1.0	Completed	ClinicalTrials
TENATUMOMAB	Antibody	breast neoplasm	Tenascin other	1.0	Terminated	ClinicalTrials
TENATUMOMAB	Antibody	connective and soft tissue neoplasm	Tenascin other	1.0	Terminated	ClinicalTrials
F16IL2	Antibody	acute myeloid leukemia	Tenascin other	1.0	Completed	ClinicalTrials
81C6 131I	Antibody	metastatic malignant neoplasm	Tenascin binding agent	1.0	Completed	ClinicalTrials
F16IL2	Antibody	non-small cell lung carcinoma	Tenascin other	1.0	Active, not recruiting	ClinicalTrials
TENATUMOMAB	Antibody	urogenital neoplasm	Tenascin other	1.0	Terminated	ClinicalTrials
F16IL2	Antibody	Merkel cell skin cancer	Tenascin other	2.0	Terminated	ClinicalTrials
TENATUMOMAB	Antibody	skin neoplasm	Tenascin other	1.0	Terminated	ClinicalTrials